Similar articles for PMID: 30849032

Year	Number of Results
2009	2
2010	2
2011	3
2012	2
2013	3
2014	6
2015	21
2016	20
2017	22
2018	20
2019	12
2020	5
2021	2
2022	3
2023	1
2024	0

1

Cancer screening: A modest proposal for prevention.

Kim MS, Nishikawa G, Prasad V. Kim MS, et al. Cleve Clin J Med. 2019 Mar;86(3):157-160. doi: 10.3949/ccjm.86a.18092. Cleve Clin J Med. 2019. PMID: 30849032 Free article. No abstract available.

2

Screening: when things go wrong.

Dickinson JA, Pimlott N, Grad R, Singh H, Szafran O, Wilson BJ, Groulx S, Thériault G, Bell NR. Dickinson JA, et al. Can Fam Physician. 2018 Jul;64(7):502-508. Can Fam Physician. 2018. PMID: 30002025 Free PMC article. No abstract available.

3

It is overtreatment, not overdiagnosis.

Patel TY. Patel TY. Acad Radiol. 2015 Aug;22(8):1044-5. doi: 10.1016/j.acra.2015.06.006. Epub 2015 Jun 19. Acad Radiol. 2015. PMID: 26100201 No abstract available.

4

Do's and don'ts in evaluation of endoscopic screening for gastrointestinal cancers.

Bretthauer M, Kalager M, Adami HO. Bretthauer M, et al. Endoscopy. 2016 Jan;48(1):75-80. doi: 10.1055/s-0034-1393094. Epub 2015 Sep 18. Endoscopy. 2016. PMID: 26382306

5

Cancer Screening, Overdiagnosis, and Regulatory Capture.

Welch HG. Welch HG. JAMA Intern Med. 2017 Jul 1;177(7):915-916. doi: 10.1001/jamainternmed.2017.1198. JAMA Intern Med. 2017. PMID: 28492850 No abstract available.

6

Screening Mammography for Average-Risk Women: The Controversy and NCCN's Position.

Helvie MA, Bevers TB. Helvie MA, et al. J Natl Compr Canc Netw. 2018 Nov;16(11):1398-1404. doi: 10.6004/jnccn.2018.7081. J Natl Compr Canc Netw. 2018. PMID: 30442738 Review.

7

Thinking beyond the treatment effect in screening for lung cancer.

Jha S. Jha S. Acad Radiol. 2015 Aug;22(8):983-4. doi: 10.1016/j.acra.2015.05.006. Epub 2015 Jun 19. Acad Radiol. 2015. PMID: 26100199 Review.

8

Breast Cancer Screening and Prevention.

Nattinger AB, Mitchell JL. Nattinger AB, et al. Ann Intern Med. 2016 Jun 7;164(11):ITC81-ITC96. doi: 10.7326/AITC201606070. Ann Intern Med. 2016. PMID: 27270661 Review.

9

A Comparative Effectiveness Trial of Alternate Formats for Presenting Benefits and Harms Information for Low-Value Screening Services: A Randomized Clinical Trial.

Sheridan SL, Sutkowi-Hemstreet A, Barclay C, Brewer NT, Dolor RJ, Gizlice Z, Lewis CL, Reuland DS, Golin CE, Kistler CE, Vu M, Harris R. Sheridan SL, et al. JAMA Intern Med. 2016 Jan;176(1):31-41. doi: 10.1001/jamainternmed.2015.7339. JAMA Intern Med. 2016. PMID: 26720730 Clinical Trial.

10

Overdiagnosis in lung cancer screening: why modelling is essential.

Ten Haaf K, de Koning HJ. Ten Haaf K, et al. J Epidemiol Community Health. 2015 Nov;69(11):1035-9. doi: 10.1136/jech-2014-204079. Epub 2015 Jun 12. J Epidemiol Community Health. 2015. PMID: 26071497 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

113 results

Results by year